Pierre Courault
Groupement Hospitalier Est
Bron, 69677, France
Bron, 69677, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Longitudinal PET Imaging of the Effects of a D2 Dopamine Receptor Antisense Oligonucleotide.
Journal: ACS chemical neuroscience
Published: March 31, 2026
Serotonergic dysfunction in patients with impulse control disorders in Parkinson's disease.
Journal: Brain : a journal of neurology
Published: July 28, 2024
Toward Functional PET Imaging of the Spinal Cord.
Journal: Seminars in nuclear medicine
Published: July 03, 2024
[18F]RS-127445 radiosynthesis and evaluation as a 5-HT2B receptor PET radiotracer in rat brain.
Journal: Bioorganic & medicinal chemistry letters
Published: July 02, 2024
PET imaging of functional 5-HT1A receptors with [18F]F13640: From PET kinetics modeling to static Standardized Uptake Values Ratio.
Journal: NeuroImage
Published: June 05, 2024
Preclinical investigation of the effect of stress on the binding of [18F]F13640, a 5-HT1A radiopharmaceutical.
Journal: Nuclear medicine and biology
Published: May 28, 2024
Perspectives on obesity imaging: [18F]2FNQ1P a specific 5-HT6 brain PET radiotracer.
Journal: International journal of obesity (2005)
Published: September 07, 2023
Amino Acid Solutions for 177Lu-Oxodotreotide Premedication: A Tolerance Study.
Journal: Cancers
Published: August 10, 2022
[18F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT1A receptors in humans.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 23, 2022
Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives.
Journal: Fundamental & clinical pharmacology
Published: September 24, 2020
Quality control of rigid endoscopes: a comparative study between ScopeControl® and surgeons' evaluation.
Journal: Surgical endoscopy
Published: August 06, 2020
Change in Expression of 5-HT6 Receptor at Different Stages of Alzheimer's Disease: A Postmortem Study with the PET Radiopharmaceutical [18F]2FNQ1P.
Journal: Journal of Alzheimer's disease : JAD
Published: May 18, 2020
Last Updated: 09/26/2026